# Endometriosis and Complement System

> **NCT06495151** · — · COMPLETED · sponsor: **Ankara City Hospital Bilkent** · enrollment: 58 (actual)

## Conditions studied

- Endometriosis
- Complement System
- Alternative Complement Pathway

## Interventions

- **DIAGNOSTIC_TEST:** Mannose-binding lectin-associated serine protease-3 (MASP-3) Level
- **DIAGNOSTIC_TEST:** Adipsin Level
- **DIAGNOSTIC_TEST:** Properdin Level
- **DIAGNOSTIC_TEST:** Complement Factor H (CFH) Level
- **DIAGNOSTIC_TEST:** Cancer Antigen 125 (CA-125) Level

## Key facts

- **NCT ID:** NCT06495151
- **Lead sponsor:** Ankara City Hospital Bilkent
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2022-06-10
- **Primary completion:** 2022-09-12
- **Final completion:** 2022-10-07
- **Target enrollment:** 58 (ACTUAL)
- **Last updated:** 2024-07-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06495151

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06495151, "Endometriosis and Complement System". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT06495151. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*